The Zacks Research Daily features new reports on Microsoft Corp. (MSFT), Anheuser-Busch InBev SA/NV (BUD), CVS Health Corp. (CVS), and micro-cap stock Stran & Co., Inc. (SWAG). Microsoft shows strong fundamentals with Azure’s 25% cloud market share. Anheuser-Busch benefits from premiumization and digital expansion. CVS Health is making progress in returning Aetna to target margins. Stran & Co. presents a compelling growth opportunity.
In the ‘Ahead of Wall Street’ article, investors can prepare for the day’s trading action by checking out the economic releases and market impacts. Today’s Featured Research Reports highlight Microsoft’s exceptional operating cash flows, Anheuser-Busch’s EBITDA margin expansion, and CVS Health’s strong financial stability. Stran & Company, Inc. is a microcap company with a compelling growth opportunity.
Microsoft’s shares have outperformed the Zacks Computer – Software industry with a 2.3% increase. Anheuser-Busch’s shares have outperformed the Zacks Beverages – Alcohol industry with a 44.5% rise. CVS Health’s shares have outperformed the Zacks Medical Services industry with a 57.3% increase. Stran & Company has outperformed the Zacks Advertising and Marketing industry with a 100% rise.
Microsoft faces competition from AWS and Google Cloud, regulatory scrutiny, and mounting capital expenditure requirements. Anheuser-Busch has been witnessing volume declines on a soft consumer landscape. CVS Health is facing ongoing pharmacy reimbursement pressures and macroeconomic concerns. Stran & Company is still unprofitable with margin pressures and cash flow challenges.

Read more at Nasdaq: Top Stock Reports for Microsoft, Anheuser-Busch & CVS Health